Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Sanpower_Group
|
| gptkbp:acquisitionYear |
2017
|
| gptkbp:focusesOn |
immunotherapy
prostate cancer treatment |
| gptkbp:founded |
1992
|
| gptkbp:founder |
gptkb:Christopher_S._Henney
|
| gptkbp:headquartersLocation |
gptkb:Seal_Beach,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Dendreon Pharmaceuticals
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:notableProduct |
gptkb:Provenge
gptkb:sipuleucel-T |
| gptkbp:parentCompany |
gptkb:Sanpower_Group
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:DNDN
|
| gptkbp:website |
https://www.dendreon.com/
|
| gptkbp:bfsParent |
gptkb:Fabrizio_Bonanni
|
| gptkbp:bfsLayer |
6
|